Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Biemond

Showing results (31-40 of 255) with videos related to

Pageof 26
Sort By:
Thrombosis and Haemostasis|March 6, 2007
Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitorBart J Biemond, Elisabeth Perzborn, Philip W Friederich, et al.
Thrombosis and Haemostasis|September 1, 1994
Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis modelB J Biemond, M Levi, M T Nurmohamed, et al.
Gastroenterology & Hepatology|April 22, 2016
Hepatosplenic T-Cell Lymphoma: A Population-Based Study Assessing Incidence and Association With Immune-Mediated DiseaseMichael Montgomery, Marije M van Santen, Bart J Biemond, et al.
American Journal of Hematology|April 9, 2020
Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)Erfan Nur, Aafke E Gaartman, Charlotte F J van Tuijn, et al.
Transfusion|September 3, 2011
Red blood cell transfusions and tissue oxygenation in anemic hematology outpatientsKoray Yuruk, Sebastiaan A Bartels, Dan M J Milstein, et al.
Circulation|February 15, 1995
Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibodyB J Biemond, M Levi, R Coronel, et al.
American Journal of Hematology|July 13, 2017
Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up studyCharlotte F J van Tuijn, Marein Schimmel, Eduard J van Beers, et al.
Thrombosis Research|November 5, 2013
Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell diseaseVeronica van der Land, Marjolein Peters, Bart J Biemond, et al.
European Journal of Haematology|February 1, 1987
Protein loss during acute graft-versus-host disease: diagnostic and clinical significanceH F Guiot, J Biemond, E Klasen, et al.
Transfusion|September 25, 2012
Transfusion of banked red blood cells and the effects on hemorrheology and microvascular hemodynamics in anemic hematology outpatientsKoray Yürük, Dan M J Milstein, Rick Bezemer, et al.
Pageof 26

Showing results (31-40 of 255) with videos related to

Sort By:
Pageof 26
Thrombosis and Haemostasis|March 6, 2007
Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitorBart J Biemond, Elisabeth Perzborn, Philip W Friederich, et al.
Thrombosis and Haemostasis|September 1, 1994
Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis modelB J Biemond, M Levi, M T Nurmohamed, et al.
Gastroenterology & Hepatology|April 22, 2016
Hepatosplenic T-Cell Lymphoma: A Population-Based Study Assessing Incidence and Association With Immune-Mediated DiseaseMichael Montgomery, Marije M van Santen, Bart J Biemond, et al.
American Journal of Hematology|April 9, 2020
Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)Erfan Nur, Aafke E Gaartman, Charlotte F J van Tuijn, et al.
Transfusion|September 3, 2011
Red blood cell transfusions and tissue oxygenation in anemic hematology outpatientsKoray Yuruk, Sebastiaan A Bartels, Dan M J Milstein, et al.
Circulation|February 15, 1995
Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibodyB J Biemond, M Levi, R Coronel, et al.
American Journal of Hematology|July 13, 2017
Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up studyCharlotte F J van Tuijn, Marein Schimmel, Eduard J van Beers, et al.
Thrombosis Research|November 5, 2013
Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell diseaseVeronica van der Land, Marjolein Peters, Bart J Biemond, et al.
European Journal of Haematology|February 1, 1987
Protein loss during acute graft-versus-host disease: diagnostic and clinical significanceH F Guiot, J Biemond, E Klasen, et al.
Transfusion|September 25, 2012
Transfusion of banked red blood cells and the effects on hemorrheology and microvascular hemodynamics in anemic hematology outpatientsKoray Yürük, Dan M J Milstein, Rick Bezemer, et al.
Pageof 26